Posted by MarketBeat News on Sep 16th, 2024
Revance Therapeutics, Inc. (NASDAQ:RVNC – Get Free Report) was the recipient of a large decline in short interest in the month of August. As of August 31st, there was short interest totalling 7,560,000 shares, a decline of 18.4%...
More of this article »